Protalix Biotherapeutics, Inc. (de) · AMEX:PLX
BlackRock, Inc. reported a 5.02% stake in Protalix Biotherapeutics, Inc. (de) (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 5.02% stake in Protalix Biotherapeutics, Inc. (de), 4,046,650 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G).
- Stake
- 5.02%
- Shares
- 4,046,650
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.02% | 4,046,650 |